Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells

Molecular and Cellular Biology

Volumn 25, Issue 4, 2005, Pages 1379-1388

  Salerno, Massimiliano ^a   Palmieri, Diane ^a   Bouadis, Amina ^a   Halverson, Douglas ^a   Steeg, Patricia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; CYCLOHEXIMIDE; HEAT SHOCK PROTEIN 90; KINASE SUPPRESSOR OF RAS1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STEADY STATE;

AMPICILLIN; BENZOQUINONES; BREAST NEOPLASMS; CELL FRACTIONATION; CELL NUCLEUS; CELL PROLIFERATION; CYCLOHEXIMIDE; CYTOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENES, TUMOR SUPPRESSOR; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; NUCLEOSIDE-DIPHOSPHATE KINASE; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN KINASE INHIBITORS; RIFABUTIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 13444278768     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.4.1379-1388.2005     Document Type: Article

References (82)

1. An, W., R. Schnur, L. Neckers, and M. Blagosklonny. 1997. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity. Cancer Chemother. Pharmacol. 40: 60-64.
2. Anselmo, A., R. Bumeister, J. Thomas, and M. White. 2002. Critical contribution of linker proteins to Raf kinase activation. J. Biol. Chem. 277:5940-5943.
3. Baba, H., T. Urano, K. Okada, K. Furukawa, E. Nakayama, H. Tanaka, K. Iwasaki, and H. Shiku. 1995. Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res. 55:1977-1981.
4. Baillat, G., S. Gaillard, F. Castets, and A. Monneron. 2002. Interactions of phocein with nucleoside diphosphate kinase, Eps15, and dynamin I. J. Biol. Chem. 277:18961-18966.
5. Basso, A., D. Solit, P. Munster, and N. Rosen. 2002. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene 21:1159-1166.
6. Bell, B., H. Xing, K. Van, N. Gautam, and A. Muslin. 1999. KSR-1 binds to G-protein bg subunits and inhibits bg-induced mitogen activated protein kinase activation. J. Biol. Chem. 274:7982-7986.
7. Bhujwalla, Z., E. Aboagye, R. Gilles, V. Chack, C. Mendola, and J. Backer. 1999. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn. Reson. Med. 41:897-903.
8. + lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin. Cancer Res. 62:1559-1566.
9. Brennan, J., D. Volle, O. V. Chaika, and R. Lewis. 2002. Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras. J. Biol. Chem. 277:5369-5377.
10. Caligo, M., G. Cipollini, A. Berti, P. Viacava, P. Collecchi, and G. Bevilacqua. 1997, NM23 gene-expression in human breast carcinomas-loss of correlation with cell-proliferation in the advanced phase of tumor progression. Int. J. Cancer 74:102-111.
11. Cuello, F., R. Schulze, F. Heemeyer, H. Meyer, S. Lutz, K. Jakobs, F. Niroomand, and T. Wieland. 2003. Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gβ subunits. J. Biol. Chem. 278:7220-7226.
12. Du, J., and G. Hannon. 2002. The centrosomal kinase Aurora-A/STK15 interacts with putative tumor suppressor NM23-H1. Nucleic Acids Res. 30:5465-5475.
13. Elion, E. 2001. The Ste5 scaffold. J. Cell Sci. 114:3967-3978.
14. Fan, Z., P. Beresford, D. Oh, D. Zhang, and J. Lieberman. 2003. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112:659-672.
15. Fishbach, M., and J. Settleman. 2003. Specific biochemical inactivation of oncogenic ras proteins by nucleoside diphosphate kinase. Cancer Res. 63: 4089-1094.
16. Fournier, H., S. Dupe-Manet, D. Bouvard, M. Laconbe, C. Marie, M. Block, and C. Albiges-Rizo. 2002. Integrin cytoplasmic domain-associated protein 1a (ICAP-1a) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. J. Biol. Chem. 277:20895-20902.
17. Fukuda, M., A. Ishii, Y. Yasutomo, N. Shimada, N. Ishikawa, N. Hanai, N. Nagara, T. Irimura, G. Nicolson, and N. Kimura. 1996. Metastatic potential of rat mammary adenocarcinoma cells associated with decreased expression of nucleoside diphosphate kinase/nm23: reduction by transfection of NDP kinase a isoform, an nm23-H2 gene homolog. Int. J. Cancer 65:531-537.
18. Goodall, R., H. Dawkins, P. Robbins, E. Hahnel, M. Sarna, R. Hahnel, J. Papadimitriou, J. Harvey, and G. Sterrett. 1994. Evaluation of the expression levels of nm23-H1 RNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue. Pathology 26:423-428.
19. Hartsough, M., D. Morrison, M. Salerno, D. Palmieri, T. Ouatas, M. Mair, J. Patrick, and P. Steeg. 2002. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of ras (KSR), via a histidine protein kinase pathway. J. Biol. Chem. 277:32389-32399.
20. Hendrix, M., E. Seftor, D. Kirschmann, and R. Seftor. 2000. Can breast cancer cells undergo vasculogenic mimicry? Br. Cancer Res. 2:417-422.
21. Isaacs, J., W. Xu, and L. Neckers. 2003. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213-217.
22. Johnson, J., S. Decker, D. Zaharevitz, L. Rubenstein, J. Vendetti, S. Schepartz, S. Kalyandrug, M. Christian, S. Arbuck, M. Hollingshead, and E. Sausville. 2001. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br. J. Cancer 84:1424-1431.
23. Kantor, J. D., B. McCormick, P. S. Steeg, and B. R. Zetter. 1993. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res. 53:1971-1973.
24. Kornfield, K., D. Hom, and H. Horvitz. 1995. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell 83:903-913.
25. Leone, A., U. Flatow, C. R. King, M. A. Sandeen, I. M. K. Margulies, L. A. Liotta, and P. S. Steeg. 1991. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 65: 25-35.
26. Leone, A., U. Flatow, K. VanHoutte, and P. S. Steeg. 1993. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization, and enzymatic activity. Oncogene 8:2325-2333.
27. Lintig, F. V., A. Dreilinger, N. Varki, A. Wallace, D. Casteel, and G. Boss. 2000. Ras activation in human breast cancer. Breast Cancer Res. Treat. 62:51-62.
28. Lombardi, D., A. Sacchi, G. D'Agostino, and G. Tibursi. 1995. The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation. Exp. Cell Res. 217:267-271.
29. Lozano, J., R. Xing, Z. Cai, H. Jensen, C. Trempus, W. Mark, R. Cannon, and R. Kolesnick. 2003. Deficiency of kinase suppressor of ras1 prevents oncogenic ras signaling in mice. Cancer Res. 63:4232-4238.
30. Luo, J., and J. Benovic. 2003. G protein-coupled receptor kinase interaction with Hsp90 mediates kinase maturation. J. Biol. Chem. 278:50908-50914.
31. MacDonald, N., J. Freije, M. Stracke, R. Manrow, and P. Steeg. 1996. Site directed mutagenesis of nm23-H1: mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J. Biol. Chem. 271:25107-25116.
32. Mahanty, S., Y. Wang, F. Farley, and E. Elion. 1999. Nuclear shuttling of yeast scaffold Ste5 is required for its recruitment to the plasma membrane and activation of the mating MAPK cascade. Cell 98:501-512.
33. Maloney, A., and P. Workman. 2002. HSP90 as a new therapeutic target for cancer therapy: the story unfolds. Expert Opin. Biol. Ther. 2:3-24.
34. Maniotis, A., R. Folberg, A. Hess, E. Seftor, L. Gardner, J. Pe'er, J. Trent, P. Meltzer, and M. Hendrix. 1999. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155:739-752.
35. Matheny, S., C. Chen, R. Kortum, G. Razidlo, R. Lewis, and M. White. 2004. Ras regulates assembly of mitogenic signalling complexes throughout the effector protein IMP. Nature 427:256-260.
36. Miele, M. E., A. D. L. Rosa, J. H. Lee, D. J. Hicks, J. U. Dennis, P. S. Steeg, and D. R. Welch. 1997. Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (nm23). Clin. Exp. Metastasis 15:259-265.
37. Miyakis, S., G. Sourvinos, and D. Spandidos. 1998. Differential expression and mutation of the ras family genes in human breast cancer. Biochem. Biophys. Res. Commun. 251:609-612.
38. Miyazaki, H., M. Fukuda, Y. Ishijima, A. Negishi, R. Hirayama, N. Ishikawa, T. Amagasa, and N. Kimura. 1999. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture. Clin. Cancer Res. 5:4301-4307.
39. Morrison, D. 2001. KSR: a MAPK scaffold of the ras pathway? J. Cell Sci. 114:1609-1612.
40. Muller, J., S. Ory, T. Copeland, H. Piwnica-Worms, and D. Morrison. 2001. C-TAK1 regulates ras signaling by phosphorylating the MAPK scaffold, KSR. Mol. Cell 8:983-993.
41. Nahta, R., G. Hortobagyi, and F. Esteva. 2003. Novel pharmacological approaches in the treatment of breast cancer. Expert Opin. Investig. Drugs 12:909-921.
42. Nguyen, A., W. Burack, J. Stock, R. Kortum, O. Chaika, M. Afkarian, W. Muller, K. Murphy, D. Morrison, R. Lewis, J. McNeish, and A. Shaw. 2002. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol. Cell. Biol. 22:3035-3045.
43. Nguyen, D., S. Desai, A. Chen, T. Weiser, and D. Schrump. 2000. Modulation of metastasis phenotypes of non-small cell lung cancer cells by 17-allylamino 17-demethoxy geldanamycin. Ann. Thorac. Surg. 70:1853-1860.
44. Nosaka, K., M. Kawahara, M. Masuda, Y. Satomi, and H. Nishino. 1998. Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. Biochem. Biophys. Res. Comm. 243:342-348.
45. Ohmachi, M., C. Rocheleau, D. Church, E. Lamhie, T. Schedl, and M. Sundaram. 2002. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation. Curr. Biol. 12:427-433.
46. Ory, S., M. Zhou, T. Conrads, T. Veenstra, and D. Morrison. 2003. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13:1356-1364.
47. Otero, A. 1997. Copurification of vimentin, energy metabolism enzymes and a MER5 homolog with nucleoside diphosphate kinase. Identification of tissue-specific interactions. J. Biol. Chem. 272:14690-14694.
48. Otsuki, Y., M. Tanaka, S. Yoshii, N. Kawazoe, K. Nakaya, and H. Sugimura. 2001. Tumor metastasis suppressor nm23H1 regulates Rac GTPase by interaction with Tiam1. Proc. Natl. Acad. Sci. USA 98:4385-4390.
49. Ouatas, T., D. Halverson, and P. Steeg. 2003. Dexamethasone and medroxy-progesterone acetate elevate Nm23-H1 metastasis suppressor expression in metastatic human breast carcinoma cells: new uses for old compounds. Clin. Cancer Res. 9:3763-3772.
50. Palacios, F., J. Schweitzer, R. Boshans, and C. D'Souza-Schorey. 2002. ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly. Nat. Cell Biol. 4:929-936.
51. Paravicini, G., M. Steinmayr, E. André, and M. Becker-André. 1996. The metastasis suppressor candidate nucleoside diphosphate kinase Nm23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily. Biochem. Biophys. Res. Commun. 227:82-87.
52. Parhar, R. S., Y. Shi, M. Zou, N. R. Farid, P. Ernst, and S. Al-Sedairy. 1995. Effects of cytokine mediated modulation of Nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int. J. Cancer 60:204-210.
53. Postel, E. 2003. Multiple biochemical activities of NM23/NDP kinase in gene regulation. J. Bioenerg. Biomembr. 35:31-40.
54. Postel, E., and B. Abramczyk. 2003. Escherichia coli nucleoside diphosphate kinase is a uracil-processing DNA repair nuclease. Proc. Natl. Acad. Sci. USA 100:13247-13252.
55. Reymond, A., S. Volorio, G. Merla, M. Al-Maghtheh, O. Zuffardi, A. Bulfone, A. Ballabio, and M. Zollo. 1999. Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene 18:7244-7252.
56. Roy, F., G. Laberge, M. Douziech, D. Ferland-McCollough, and M. Therrien. 2002. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16:427-438.
57. Roymans, D., K. Vissenberg, C. DeJonghe, R. W. G. Engler, N. Kimura, B. Grobben, P. Claes, J. Verbelen, C. VanBroeckhoven, and H. Slegers. 2001. Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constitutent of the centrosome. Exp. Cell Res. 262:145-153.
58. Roymans, D., R. Willens, K. Vissenberg, C. DeJonghe, B. Groben, P. Claes, I. Lascu, D. V. Bockstaele, J. Verbelen, C. VanBroeckhoven, and H. Slegers. 2000. Nucleoside diphosphate kinase b (Nm23-R1/NDPKb) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Exp. Cell Res. 261:127-138.
59. Russell, R., A. Pedersen, J. Kantor, K. Geisinger, R. Long, N. Zbieranski, A. Townsend, B. Shelton, N. Brunner, and T. Kute. 1998. Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines. Br. J. Cancer 78:710-717.
60. Sausville, E., Y. Elsayed, M. Monga, and G. Kim. 2003. Signal transduction-directed cancer treatments. Annu. Rev. Pharmacol. Toxicol. 43:199-231.
61. Schondorf, T., A. Andrack, D. Niederacher, A. Scharl, M. Becker, H. Engel, and U. Gohring. 1999. H-ras gene amplification or mutation is not common in human primary breast cancer. Oncol. Rep. 6:1029-1033.
62. Sellappan, S., R. Grijalva, X. Zhou, W. Yang, M. B. Eli, G. Mills, and D. Yu. 2004. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res. 64:3479-3485.
63. Siddiqui-Jain, A., C. Grand, D. Bearss, and L. Hurley. 2002. Direct evidence for a G-quadruplex in a promoter region and its targeting with a samll molecule to repress C-MTC transcription. Proc. Natl. Acad. Sci. USA 99: 11593-11598.
64. Steeg, P. 2003. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Cancer Rev. 3:55-63.
65. Stewart, S., M. Sundaram, Y. Zhang, J. Lee, M. Han, and K. Guan. 1999. Kinase suppressor of ras forms a multiprotein signaling complex and modulates MEK localization. Mol. Cell. Biol. 19:5523-5534.
66. Subramanian, C., M. Cotter, and E. Robertson. 2001. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat. Med. 7:350-355.
67. Sundaram, M., and M. Han. 1995. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell 83: 889-901.
68. Suzuki, E., T. Ota, K. Tsukuda, A. Okita, K. Matsuoka, M. Murakami, H. Doihara, and N. Shimizu. 2004. nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int. J. Cancer 108:207-211.
69. Tagashira, H., K. Hamazaki, N. Tanaka, C. Gao, and M. Namba. 1998. Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2 rat nucleoside diphosphate kinase a isoform. Int. J. Mol. Med. 2:65-68.
70. Therrien, M., H. Chang, N. Solomon, F. Karim, D. Wassarman, and G. Rubin. 1995. KSR, a novel protein kinase required for RAS signal transduction. Cell 83:879-888.
71. Toulas, C., J. Mihura, C. de Balincourt, B. Marques, E. Marek, G. Soula, H. Roche, and G. Favre. 1996. Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibody. Br. J. Cancer 73:630-635.
72. Tseng, Y., D. Vincent, J. Zhu, A. Adeyinka, J. Moyers, P. Watson, and C. Kahn. 2001. Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and Nm23. Cancer Res. 61:2071-2079.
73. Wagner, P., and N.-D. Vu. 2000. Histidine to aspartate phosphotransferase activity of nm23 protein: phosphorylation of aldolase C on Asp 319. Biochem. J. 346:623-630.
74. Wagner, P., and N.-D. Vu. 1995. Phosphorylation of ATP-citrate lyase by nucleoside diphosphate kinase. J. Biol. Chem. 270:21758-21764.
75. Webb, C., C. Hose, S. Koochekpour, M. Jeffers, M. Oskarsson, E. Sausville, A. Monks, and G. VandWoude. 2000. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-pasmin proteolytic network. Cancer Res. 60:342-349.
76. Xing, H., C. Cordon-Cardo, X. Deng, W. Tong, L. Campodonico, Z. Fuks, and R. Kolesnick. 2003. Pharmacologicinactivation of kinase suppressor of ras-1 abrogates ras-mediated pancreatic cancer. Nat. Med. 9:1267-1268.
77. Xing, H., and R. Kolesnick. 2001. Kinase suppressor of ras signals through Thr269 of c-Raf-1. J. Biol. Chem. 276:9733-9741.
78. Xu, J., L. Liu, F. Deng, L. Timmons, E. Hersperger, P. Steeg, M. Veron, and A. Shearn. 1996. Rescue of the awd mutant phenotype by expression of human Nm23/NDP kinase in Drosophila. Dev. Biol. 177:544-557.
79. Yaguchi, H., N. Ohkura, T. Tsukada, and K. Yamaguchi. 2002. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J. Biol. Chem. 277:38197-38204.
80. Yan, F., and B. Polk. 2001. Kinase suppressor of ras is necessary for tumor necrosis factor a activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 61:963-989.
81. Yoder, J., H. Chong, K.-L. Guan, and M. Han. 2004. Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase. EMBO J. 23:1-9.
82. Zhu, J., Y.-H. Tseng, J. Kantor, C. Rhodes, B. Zetter, J. Moyers, and C. Kahn. 1999. Interaction of the Ras-related protein associated with diabetes Rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation. Proc. Natl. Acad. Sci. USA 96:14911-14918.